Some of the best minds in the business when it comes to studying schizophrenia are convening at the Fralin Biomedical Research Institute in Roanoke today and tomorrow, to explore more precise treatments for a mental health condition that affects how a person thinks and behaves, and often results in hallucinations. Examining how schizophrenia may be redefined through advances in computational phenotyping and next-generation pharmacology. Integrating brain, behavioral, and biological data, Dr Michael Halassa from the FBRI, a joint venture with Virginia Tech and Carilion, is co-host of a symposium that features guest speakers from academia and the pharmaceutical world. He says new “wonder drugs” are constantly arriving on the market. More on the “Precision Therapeutics Symposium” from WFIR’s Gene Marrano:
https://wfirnews.com/wp-content/uploads/2026/09/9-23-Schizo-Wrap1-WEB.mp3The post Precision Therapeutics Symposium at FBRI focuses on better treatment plans for schizophrenia first appeared on News/Talk 960-AM & FM-107.3 WFIR.